Lactobio launches Rescue Serum for Acne-prone Skin
Recently, the research-based company, Lactobio, launched a new product comprising live lactic acid bacteria (LAB) for acne-prone skin. Underpinned by research into the skin microbiome and new probiotic bacterial strains, the product combines highly potent bacterial strains (LB356R & LB244R) with natural ingredients to eliminate pimples and spots.
“After several years of research, we are super excited to launch our first product for acne-prone skin. As with all our products, the goal was to create a revolutionary skincare product that combines high potency with a positive effect on the skin ecosystem,” says CEO Søren Kjærulff.
As one of only companies worldwide with live probiotic bacteria in topical skincare, Lactobio is looking to advance research on microbiome-related skin diseases by spending in the range of 70-80% of its budget on R&D — precisely the reason the founders studied biology in the first place.
Lactobio has now identified new LAB, which are specifically co-aggregating with the pathogenic ribotypes of C. acnes – preventing it from dominating the skin microbiome.
The response from the Danish market has been overwhelming and Lactobio is therefore looking for international partners for distribution. Looking at the global market for acne drugs, it was valued at USD 4.1 billion in 2017 and is anticipated to register a CAGR of 4.2% expected to reach USD 5.9 billion by 2025 and 86% of US consumers aged 18-34 have used or are interested in using probiotic facial skincare (Grand View Research, Inc).
For further information, please contact:
CCO Erik Rasmussen
Lactobio develops cosmeceuticals, dietary supplements and live biotherapeutic products to target pathogens and microbiome dysfunctions associated with specific diseases. Lactobio has a state-of-the-art BSL2 Microbiology Laboratory where our research scientists with PhDs in microbiology, biotechnology and biochemistry identify, select and grow the best probiotic strains to fight pathogenic bacteria, including multiresistant bacteria.
Lactobio launched their first cosmeceutical product for atopic skin in 2019. The commercialization was both B2B (white label) with international partners and B2C as Bak Probiotic Skincare in EU and at Danish Pharmacies through Nomeco. Lactobio has four products that effectively rebalances dysbiosed skin microbiomes and fights pathogenic bacteria like Staphylococcus aureus cc1 and Cutibacterium acnes.